iThe aims of the administrative core are to set and implement programmafic goals and operafing procedures ,or the overall research as well as facilitate communicafion between projects and cores. Moreover, the core will monitor and develop scientific exchanges among all invesfigators and the Internal and External Advisory Committees. This will provide monitoring for scientific progress;maintain a system for fiscal accountability;oversee confiict of interests;provide broad statisfical support, and assist in the planning, implementafion of experiments and interpretafion of data for publications, patent applicafions, and ulfimately a pathway towards clinical product development. Most importanfiy the core will serve to integrate research activifies ongoing between each of the projects and the scientific cores. Dr. H. Gendelman will serve to organize and implement all acfivifies and will be assisted by a program coordinator, Dr. R. L. Mosley and a scientific codirector. Dr. H. Fox. The biostatisfical core will be led by Dr. Jane Meza;an experienced biostafistical expert.
Antiretroviral therapies are the mainstay for HIV/AIDS treatments. Drug access, adherence, compliance and untoward toxicifies remain commonplace and most notably for substance abusers. We posit that specific drug targefing to sites of acfive viral growth in a safe, extended-release injectable formula will improve disease outcomes and have profound posifive clinical outcomes for substance abusers.
| Ottemann, Brendan M; Helmink, Austin J; Zhang, Wenting et al. (2018) Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities. Biomaterials 185:174-193 |
| Zhou, Tian; Su, Hang; Dash, Prasanta et al. (2018) Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials 151:53-65 |
| Kevadiya, Bhavesh D; Ottemann, Brendan M; Thomas, Midhun Ben et al. (2018) Neurotheranostics as personalized medicines. Adv Drug Deliv Rev : |
| Gautam, Nagsen; Lin, Zhiyi; Banoub, Mary G et al. (2018) Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS. J Pharm Biomed Anal 153:248-259 |
| Zhou, Tian; Lin, Zhiyi; Puligujja, Pavan et al. (2018) Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals. Nanomedicine (Lond) 13:871-885 |
| Kiyota, Tomomi; Machhi, Jatin; Lu, Yaman et al. (2018) Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice. J Neuroimmunol 319:80-92 |
| McMillan, JoEllyn M; Cobb, Denise A; Lin, Zhiyi et al. (2018) Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice. J Pharmacol Exp Ther 365:272-280 |
| McMillan, JoEllyn; Szlachetka, Adam; Zhou, Tian et al. (2018) Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques. AIDS : |
| Montenegro-Burke, J Rafael; Woldstad, Christopher J; Fang, Mingliang et al. (2018) Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress. Mol Neurobiol : |
| Olson, Katherine E; Bade, Aditya N; Namminga, Krista L et al. (2018) Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. J Neurovirol 24:398-410 |
Showing the most recent 10 out of 141 publications
